Charles River Laboratories International (MIL:1CRL) Moat Score: 6/10 (As of Jul. 05, 2026)


MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
70 GF Score
Price €143.90
GF Value €121.29
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Moat Score?

Charles River Laboratories International MIL:1CRL 70 Moat Score is 6 as of Jul. 05, 2026. GuruFocus rates MIL:1CRL with a GF Score™ of 70/100 and a GF Value™ of €121.29. The stock has 8 warning signs investors should review. Among 217 Medical Diagnostics & Research companies, Charles River Laboratories International ranks better than 94.01% on this metric.

Charles River Laboratories International has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Charles River Laboratories International has Narrow Moat: Charles River Laboratories has a strong position in the research and development sector with valuable intellectual property and a robust distribution network. However, while it has a strong narrow moat, it lacks the dominance required for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Charles River Laboratories International might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Charles River Laboratories International  (MIL:1CRL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Charles River Laboratories International Moat Score Related Terms

MIL:1CRL vs RVTY, QGEN, ICLR: Moat Score Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Charles River Laboratories International Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Moat Score distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Moat Score falls into.


MIL:1CRL
70GF Score
Charles River Laboratories International Inc MIL:1CRL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Charles River Laboratories International (MIL:1CRL) has a Moat Score of 6 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Charles River Laboratories International ranks #13 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 6%.
Is Charles River Laboratories International's Moat Score too high?
Charles River Laboratories International's current Moat Score is 6. Based on the distribution chart, Charles River Laboratories International ranks #13 out of 217 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Moat Score compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #13 out of 217 companies for Moat Score. This places Charles River Laboratories International in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Charles River Laboratories International's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Moat Score of 6. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Moat Score is 6. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Moat Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.

Key valuation signals for MIL:1CRL:

  • Moat Score: 6
  • GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score

Get the complete analysis for MIL:1CRL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€121.29
GF Value